The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. MBX Biosciences Inc shares valued at $11,999,988 were purchased by Heron Patrick J on Sep 26 ’25. At $18.00 per share, Heron Patrick J acquired 666,666 shares. The insider’s holdings grew to 5,219,440 shares worth approximately $87.43 million following the completion of this transaction.
Also, Pescovitz Ora H. purchased 7,693 shares, netting a total of over 45,312 in proceeds. Following the buying of shares at $5.89 each, the insider now holds 24,329 shares.
Before that, GORDON CARL L had added 143,170 shares to its account. In a trade valued at $1,551,963, the Director bought MBX Biosciences Inc shares for $10.84 each. Upon closing the transaction, the insider’s holdings increased to 143,170 shares, worth approximately $54.52 million.
Analysts at Mizuho started covering the stock with ‘”an Outperform”‘ outlook in a report released in early August. As of July 16, 2025, Oppenheimer has initiated its “an Outperform” rating for MBX. Earlier on April 10, 2025, Citizens JMP initiated its rating. Their recommendation was “a Mkt outperform” for MBX stock.
Analyzing MBX Stock Performance
On last trading session, MBX Biosciences Inc [NASDAQ: MBX] plunged -6.42% to $16.75. The stock’s lowest price that day was $16.66, but it reached a high of $18.21 in the same session. During the last five days, there has been a drop of approximately -3.35%. Over the course of the year, MBX Biosciences Inc shares have dropped approximately -35.53%. Shares of the company reached a 52-week high of $26.47 on 09/22/25 and a 52-week low of $4.81 on 04/07/25.
Support And Resistance Levels for MBX Biosciences Inc (MBX)
According to the 24-hour chart, there is a support level at 16.20, which, if violated, would cause prices to drop to 15.66. In the upper region, resistance lies at 17.75. The next price resistance is at 18.76. RSI (Relative Strength Index) is 56.53 on the 14-day chart, showing neutral technical sentiment.
Is MBX Biosciences Inc subject to short interest?
Stocks of MBX Biosciences Inc saw a sharp rise in short interest on 2025-09-15 jumping by 0.16 million shares to 4.23 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 4.07 million shares. A jump of 3.81% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.21 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.21.
Which companies own the most shares of MBX Biosciences Inc (MBX)?
In terms of MBX Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 38 in the next 12 months, up nearly 112.29% from the previous closing price of $17.9. Analysts anticipate MBX Biosciences Inc stock to reach 38 by 2025, with the lowest price target being 38. On October 08, 2024, Stifel assigned a price target of “a Buy” to the stock and initiated coverage with a $40.
